Clonidine withdrawal. Mechanism and frequency of rebound hypertension
- PMID: 760743
- PMCID: PMC1429594
- DOI: 10.1111/j.1365-2125.1979.tb00897.x
Clonidine withdrawal. Mechanism and frequency of rebound hypertension
Abstract
1. The frequency and pathophysiology of the clonidine withdrawal syndrome was studied in fourteen hypertensive patients on chronic clonidine therapy. 2. After sudden cessation of clonidine (900 microgram daily) almost all of the patients showed an excessive increase of the heart rate and blood pressure. Seven of the fourteen patients had subjective symptoms, in three severe enough to require interruption of observation by therapeutic intervention 12 to 60 h after the last dose of clonidine. After clonidine withdrawal, NAE increased to abnormally high values in correlation with the blood pressure (P less than 0.01) and heart rate (P less than 0.001), whereas PRA even decreased initially, probably secondary to the rise of the blood pressure, and only rose, although not significantly, 48 h after withdrawal. PRA was not correlated with NAE, heart rate, or blood pressure. 3. It is concluded that the clonidine withdrawal phenomenon is a frequently occurring and potentially dangerous syndrome. Overactivity of the sympathetic nervous system is mainly responsible, without the mediation of the renin angiotensin system. This also explains our experience that adrenergic beta-receptor blocking drugs do not prevent the rise in BP, although they alleviate some of the symptoms.
Similar articles
-
Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.Cardiovasc Drugs Ther. 1996 Jun;10 Suppl 1:251-62. doi: 10.1007/BF00120495. Cardiovasc Drugs Ther. 1996. PMID: 8827948
-
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline.Lancet. 1977 Jun 4;1(8023):1171-4. doi: 10.1016/s0140-6736(77)92715-5. Lancet. 1977. PMID: 68274
-
Regimen for the control of blood pressure and symptoms during clonidine withdrawal.Int J Clin Pharmacol Res. 1985;5(4):215-22. Int J Clin Pharmacol Res. 1985. PMID: 4055164
-
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005. Drugs. 1984. PMID: 6151891 Review.
-
Drugs five years later: clonidine.Ann Intern Med. 1980 Jan;92(1):74-7. doi: 10.7326/0003-4819-92-1-74. Ann Intern Med. 1980. PMID: 6101302 Review.
Cited by
-
Alpha-2 Agonists in Children and Adolescents With Post-traumatic Stress Disorder: A Systematic Review.Cureus. 2024 Jan 26;16(1):e53009. doi: 10.7759/cureus.53009. eCollection 2024 Jan. Cureus. 2024. PMID: 38410304 Free PMC article. Review.
-
Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.Cardiovasc Drugs Ther. 1996 Jun;10 Suppl 1:251-62. doi: 10.1007/BF00120495. Cardiovasc Drugs Ther. 1996. PMID: 8827948
-
Radioligand binding studies of adrenergic receptors and their clinical relevance.Br Med J (Clin Res Ed). 1981 Apr 11;282(6271):1207-10. doi: 10.1136/bmj.282.6271.1207. Br Med J (Clin Res Ed). 1981. PMID: 6265022 Free PMC article. Review. No abstract available.
-
Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):157S-164S. doi: 10.1111/j.1365-2125.1980.tb04924.x. Br J Clin Pharmacol. 1980. PMID: 6994770 Free PMC article.
-
Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects.Intensive Care Med. 2004 Dec;30(12):2188-96. doi: 10.1007/s00134-004-2417-z. Epub 2004 Aug 26. Intensive Care Med. 2004. PMID: 15338124 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials